SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-064095
Filing Date
2024-08-01
Accepted
2024-08-01 16:15:15
Documents
17
Period of Report
2023-12-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea021004502-8ka1_aditxtinc.htm   iXBRL 8-K/A 48534
2 AUDITED FINANCIAL STATEMENTS OF EVOFEM BIOSCIENCES, INC. AND SUBSIDIARIES AS OF ea021004502ex99-1_aditxtinc.htm EX-99.1 901776
3 UNAUDITED FINANCIAL STATEMENTS OF EVOFEM BIOSCIENCES, INC. AND SUBSIDIARIES AS O ea021004502ex99-2_aditxtinc.htm EX-99.2 444754
4 UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION AS OF AND FOR THE THREE MONTH ea021004502ex99-3_aditxtinc.htm EX-99.3 260693
5 UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 ea021004502ex99-4_aditxtinc.htm EX-99.4 244072
  Complete submission text file 0001213900-24-064095.txt   2296185

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adtx-20231211.xsd EX-101.SCH 3009
7 XBRL LABEL FILE adtx-20231211_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE adtx-20231211_pre.xml EX-101.PRE 22355
19 EXTRACTED XBRL INSTANCE DOCUMENT ea021004502-8ka1_aditxtinc_htm.xml XML 6605
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39336 | Film No.: 241166885
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)